Filing Details
- Accession Number:
- 0000905148-23-001450
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-11-14 18:29:04
- Reporting Period:
- 2023-11-10
- Accepted Time:
- 2023-11-14 18:29:04
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1604464 | Atara Biotherapeutics Inc. | ATRA | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1214939 | K William Heiden | C/O Atara Biotherapeutics, Inc. 2380 Conejo Spectrum St, Suite 200 Thousand Oaks CA 91320 | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2023-11-10 | 100,000 | $0.25 | 209,000 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Footnotes
- Represents the weighted average purchase price. The shares were purchased in multiple transactions at prices ranging from $0.2489 to $0.265. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this Form 4.
Billionaire Hedge Funds
